产品名称 | Seraseq® 22q11 Male-Matched Reference Material (SeraCare) |
---|---|
目录号 | 0720-0173 |
别名 | N/A |
外观 | N/A |
分子量 | N/A |
CAS | N/A |
溶解度 | N/A |
存储条件 | N/A |
保存时间 | N/A |
备注1 | N/A |
备注2 | N/A |
目录号 | 规格 | 价格 | 库存状态 | |
0720-0173 | 1 x 1 mL | 咨询客服 | 咨询客服 |
品名:Seraseq® 22q11 Male-Matched Reference Material
货号:0720-0173
品牌:SeraCare
Details
Non-invasive prenatal testing (NIPT) continues to expand globally and given the clinical implications, it is extremely
critical that NIPT assays report back presence or absence of aneuploidies in an accurate and consistent manner.
Matched maternal-fetal reference materials derived from pregnant maternal plasma enable accurate assessment of
a broad range of NIPT assays, including those based on counting methods, SNPs, as well as differences in the length
of maternal and fetal cfDNA.
The Seraseq 22q11 Male-Matched Reference Material can be used to develop a new test, validate an assay, monitor
routine performance, troubleshoot problems across the entire workflow and ensure overall proficiency with the same
sustainable product.
Matched (or related) maternal-fetal 22q11 (or DiGeorge Syndrome) male sample compatible with a broad range of
NIPT assay methods
Microdeletion is at least 2Mb and includes TUPLE1 deletion Proprietary method maintains native cfDNA size profile
of ~170 bp size distribution and natural maternal-fetal size difference
Offered in a plasma format capable of assessing the entire workflow from extraction through analysis
(similar to clinical samples)
Fetal fraction levels confirmed to be a high positive to help establish initial baseline
(can be customized to lower levels)
Manufactured in GMP-compliant and ISO 13485-certified facilities
维百奥生物代理SeraCare对照及参比物质。
维百奥(北京)生物科技有限公司,自2018年与SeraCare(现隶属于LGC Clinical Diagnostics)合作以来,长期为中国客户
提供包括SeraSeq系列参比物质,领域包括肿瘤、生殖健康和遗传病。SeraCare研发和生产一系列临床参比物质,可以用于任何
研发阶段,以确保临床基因组学检测结果的准确性。
SeraCare参比物质涵盖的范围:
1)Next Generation Sequencing
2)Sanger Sequencing
3)Real-time PCR and digital PCR (dPCR)
4)Microarray
主要特点
1)Ready-to-use reference materials covering clinically-relevant variants and all variant types - SNVs, INDELS, CNVs,
and RNA fusions
2)Highly multiplexed - provide significantly more data per NGS run, saving sequencing costs
3)Available in multiple formats to suite different workflow needs - purified DNA & RNA, ctDNA, encapsulated ctDNA
in plasma, and FFPE
4)Manufactured in cGMP-compliant, ISO 13485-certified facilities
5)Stringent product release testing - all variants qualified by dPCR for allele frequencies or copy numbers